Publicaciones
-
Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A, Bonaguro R, Chinthrajah S, Lack G, Fiocchi A, Le TM, Turner P, Alvaro-Lozano M, Angier E, Barni S, Bégin P, Ballmer-Weber B, Cardona V, Bindslev-Jensen C, Cianferoni A, de Jong N, de Silva D, Deschildre A, Galvin AD, Ebisawa M, Fleischer DM, Gerdts J, Giovannini M, Gradman J, Halken S, Arshad SH, Khaleva E, Lau S, Loh R, Mäkelä MJ, Marchisotto MJ, Morandini L, Mortz CG, Nilsson C, Nowak-Wegrzyn A, Podestà M, Poulsen LK, Roberts G, Rodríguez Del Río P, Sampson HA, Sánchez A, Schnadt S, Smith PK, Szajewska H, Mitrevska NT, Toniolo A, Venter C, Warner A, Wong GWK, Wood R and Worm M.
GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
Clinical and Translational Allergy . 14(11): .
-
Rodríguez Del Río P, Alvaro-Lozano M, Arasi S, Bazire R, Escudero C, Patel N, Mónica Paola Sandoval Ruballos, Vazquez-Ortiz M, Nowak-Wegrzyn A, Blümchen K, Dunn Galvin A, Deschildre A, Greenhawt M, Schnadt S, Riggioni C, Remington BC, Turner P and Fernandez Rivas M.
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
ALLERGY . 79(4): 793-822. Nº de citas: 6
-
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, Hourihane JO, Jones CJ, Jutel M, Knol E, Konstantinou GN, Lack G, Lau S, Marques Mejias A, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, Lopes de Oliveira LC, O'Mahony L, Papadopoulos NG, Perrett K, Peters RL, Podesta M, Poulsen LK, Roberts G, Sampson HA, Schwarze J, Smith P, Tham EH, Untersmayr E, Van Ree R, Venter C, Vickery BP, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G and Skypala I.
EAACI guidelines on the diagnosis of IgE-mediated food allergy
ALLERGY . 78(12): 3057-3076. Nº de citas: 52
-
Staubach P, Alvaro-Lozano M, Sekerel BE, Maurer M, Ben-Shoshan M, Porter M, Hua E, Ji Y, Burciu A, Savelieva M, Severin T, Drollmann A and Bienczak A.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis
PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(7): . Nº de citas: 7
-
Sahiner, UM, Giovannini, M, Escribese, MM, Paoletti, G, Heffler, E, Alvaro-Lozano M, Barber, D, Canonica, GW and Pfaar, O.
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Journal of Personalized Medicine . 13(5): . Nº de citas: 13
-
Mónica Paola Sandoval Ruballos, Domínguez-Sánchez O, de Landazuri, IO, Daniella Gereda Martinez, Michel Espinoza Cisneros, Sequeira, FQ, Rodriguez, SMR, Machinena A, Piquer-Gibert M, Folqué-Giménez MM, Lozano-Blasco J, Jiménez-Feijoo R, Pascal, M and Alvaro-Lozano M.
Pediatric chronic urticaria: Clinical and laboratory characteristics and factors linked to remission
PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(3): . Nº de citas: 3
-
Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner PJ, Shinder SB, Gupta R, Eigenmann P, Nowak-Wegrzyn A, Ansotegui IJ, Rivas MF, Petrou S, Tanno LK, Vazquez-Ortiz M, Vickery B, Wong G, Alvaro-Lozano M, Asaria M, Begin P, Bozzola M, Boyle R, Brough H, Cardona V, Chinthrajah RS, Cianferoni A, Deschildre A, Fleischer D, Gazzani F, Gerdts J, Giannetti M, Greenhawt M, Guzmán MA, Hossny E, Kauppi P, Jones C, Lucidi F, Monge Ortega OP, Munblit D, Muraro A, Pajno G, Podestà M, Rodriguez Del Rio P, Said M, Santos A, Shaker M, Szajewska H, Venter C, Warren C, Winders T, Ebisawa M and Fiocchi A.
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
World Allergy Organization Journal . 16(3): 100753-100753. Nº de citas: 15
-
Munblit D, Greenhawt M, Brough HA, Pushkareva A, Karimova D, Demidova A, Warner JO, Kalayci O, Sediva A, Untersmayr E, Rodriguez Del Rio P, Vazquez-Ortiz M, Arasi S, Alvaro-Lozano M, Tsabouri S, Galli E, Beken B and Eigenmann PA.
Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics
PEDIATRIC ALLERGY AND IMMUNOLOGY . 33(10): . Nº de citas: 6
-
de Silva D, Singh C, Arasi S, Muraro A, Zuberbier T, Ebisawa M, Alvaro-Lozano M and Roberts G.
Systematic review of monotherapy with biologicals for children and adults with IgE-mediated food allergy
Clinical and Translational Allergy . 12(9): . Nº de citas: 11
-
Muraro A, de Silva D, Halken S, Worm M, Khaleva E, Arasi S, Dunn-Galvin A, Nwaru BI, De Jong NW, Rodríguez Del Río P, Turner PJ, Smith P, Begin P, Angier E, Arshad H, Ballmer-Weber B, Beyer K, Bindslev-Jensen C, Cianferoni A, Demoulin C, Deschildre A, Ebisawa M, Fernandez-Rivas MM, Fiocchi A, Flokstra-de Blok B, Gerdts J, Gradman J, Grimshaw K, Jones C, Lau S, Loh R, Alvaro-Lozano M, Makela M, Marchisotto MJ, Meyer R, Mills C, Nilsson C, Nowak-Wegrzyn A, Nurmatov U, Pajno G, Podestà M, Poulsen LK, Sampson HA, Sanchez A, Schnadt S, Szajewska H, Van Ree R, Venter C, Vlieg-Boerstra B, Warner A, Wong G, Wood R, Zuberbier T and Roberts G.
Managing food allergy: GA2LEN guideline 2022
World Allergy Organization Journal . 15(9): 100687-100687. Nº de citas: 83